Center for Computational Biotechnology and Genomic Medicine (CCBGM) An NSF Industry/University Cooperative Research Center

Liewei Wang, Co-PI, is Associate Director of the Pharmacogenomics Program within the Center for Individualized Medicine (CIM) at Mayo Clinic. She is a Professor in the Dept. of Molecular Pharmacology and Experimental Therapeutics (MPET) and Co-PI of the Mayo NIH Pharmacogenomics Research Network (PGRN). Her research focuses on application of high-throughput genomic assays in identifying and understanding the molecular mechanisms associated with biomarkers responsible for variation in drug response.